Afficher la couverture 'International Consensus on Use of Continuous Glucose Monitoring | Danne, Thomas' en grand format
/5

0 avis

International Consensus on Use of Continuous Glucose Monitoring

Archive ouverte

Danne, Thomas | Nimri, Revital | Battelino, Tadej | Bergenstal, Richard M. | Close, Kelly L. | Devries, J. Hans | Garg, Satish | Heinemann, Lutz | Hirsch, Irl | Amiel, Stephanie A. | Beck, Roy | Bosi, Emanuele | Buckingham, Bruce | Cobelli, Claudio | Dassau, Eyal | Doyle, Francis J. | Heller, Simon | Hovorka, Roman | Jia, Weiping | Jones, Tim | Kordonouri, Olga | Kovatchev, Boris | Kowalski, Aaron | Laffel, Lori | Maahs, David | Murphy, Helen R. | Nørgaard, Kirsten | Parkin, Christopher G. | Renard, Eric | Saboo, Banshi | Scharf, Mauro | Tamborlane, William V. | Weinzimer, Stuart A. | Phillip, Moshe

Edité par CCSD ; American Diabetes Association -

International audience. Measurement of glycated hemoglobin (HbA1c) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday glycemic excursions that may lead to acute events (such as hypoglycemia) or postprandial hyperglycemia, which have been linked to both microvascular and macrovascular complications. Continuous glucose monitoring (CGM), either from real-time use (rtCGM) or intermittently viewed (iCGM), addresses many of the limitations inherent in HbA1ctesting and self-monitoring of blood glucose. Although both provide the means to move beyond the HbA1cmeasurement as the sole marker of glycemic control, standardized metrics for analyzing CGM data are lacking. Moreover, clear criteria for matching people with diabetes to the most appropriate glucose monitoring methodologies, as well as standardized advice about how best to use the new information they provide, have yet to be established. In February 2017, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address these issues. This article summarizes the ATTD consensus recommendations and represents the current understanding of how CGM results can affect outcomes.

Consulter en ligne

Suggestions

Du même auteur

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

Archive ouverte | Battelino, Tadej | CCSD

International audience. Improvements in sensor accuracy, greater convenience and ease of use, and expanding reimbursement have led to growing adoption of continuous glucose monitoring (CGM). However, successful util...

Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice

Archive ouverte | Phillip, Moshe | CCSD

International audience. The significant and growing global prevalence of diabetes continues to challenge people with diabetes (PwD), healthcare providers and payers. While maintaining near-normal glucose levels has ...

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Archive ouverte | Battelino, Tadej | CCSD

International audience. Randomised controlled trials and other prospective clinical studies for novel medical interventions in people with diabetes have traditionally reported HbA1c as the measure of average blood g...

Chargement des enrichissements...